miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 492-498

  Wang, De Tao ^a   Ma, Zhong Liang ^a   Li, Yan Li ^a   Wang, Yue Qing ^a   Zhao, Bo Tao ^a   Wei, Jia Li ^a   Qiu, Xiang ^a   Zhao, Xin Tai ^c   Jin, You Xin ^a,b  

^a SHANGHAI UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c Shanghai X Pharm R/D Co Ltd   (China)

Author keywords

miR 150; miRNA; NSCLC; p53 protein

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 10A; MICRORNA 148; MICRORNA 150; MICRORNA 181A; MICRORNA 182; MICRORNA 184; MICRORNA 34A; MICRORNA 34C; PROTEIN P53; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE DISTRIBUTION; CELL CYCLE PARAMETERS; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA VECTOR; DOWN REGULATION; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TISSUE SECTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

3' UNTRANSLATED REGIONS; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878173440     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2453     Document Type: Article

References (42)

1. Zabaleta J: MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development. Front Genet 3: 294, 2012.
2. Harquail J, Benzina S and Robichaud GA: MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark 11: 269-280, 2012.
3. Wang F, Sun GP, Zou YF, Hao JQ, Zhong F and Ren WJ: MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark 11: 259-267, 2012.
4. Odjele A, Charest D and Morin PJ: miRNAs as important drivers of glioblastomas: a no-brainer? Cancer Biomark 11: 245-252, 2012.
5. Eldem V, Celikkol Akcay U, Ozhuner E, Bakir Y, Uranbey S and Unver T: Genome-wide identification of miRNAs responsive to drought in peach (Prunus persica) by high-throughput deep sequencing. PloS One 7: e50298, 2012.
6. Endo H, Muramatsu T, Furuta M, et al: Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer. Carcinogenesis 34: 560-569, 2013.
7. Li KK, Pang JC, Lau KM, et al: miR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol: Dec 11, 2012 (Epub ahead of print). doi: 10.1111/bpa.12014
8. Masuda M, Miki Y, Hata S, et al: An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma. J Transl Med 10 (Suppl 1): S2, 2012.
9. Novello C, Pazzaglia L, Cingolani C, et al: miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42: 667-675, 2013.
10. Ando H, Okamoto A, Yokota M, et al: Development of miR-92a delivery system for antiangiogenesis-based cancer therapy. J Gene Med 15: 20-27, 2012.
11. Teixeira AL, Gomes M and Medeiros R: EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. Front Genet 3: 286, 2012.
12. Boldrup L, Coates PJ, Wahlgren M, Laurell G and Nylander K: Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog 11: 18, 2012.
13. Hirata H, Ueno K, Shahryari V, et al: Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PloS One 7: e51056, 2012.
14. Hassan F, Nuovo GJ, Crawford M, et al: MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PloS One 7: e50837, 2012.
15. Sasaki A, Udaka Y, Tsunoda Y, et al: Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines. Anticancer Res 32: 4709-4713, 2012.
16. Suzuki HI and Miyazono K: p53 actions on microRNA expression and maturation pathway. Methods Mol Biol 962: 165-181, 2013.
17. Gurtler A, Kunz N, Gomolka M, et al: Stain-Free technology as a normalization tool in Western blot analysis. Anal Biochem 433: 105-111, 2012.
18. Hirano S: Western blot analysis. Methods Mol Biol 926: 87-97, 2012.
19. Kao CH, Cheng CM, Chuang KH, et al: A regularly spaced and self-revealing protein ladder for anti-tag Western blot analysis. Anal Biochem 431: 1-3, 2012.
20. Nybo K: Molecular biology techniques Q&A. Western blot: protein migration. Biotechniques 53: 23-24, 2012.
21. Li XJ, Ji MH, Zhong SL, et al: MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Arch Med Res 43: 514-521, 2012.
22. Siemens H, Neumann J, Jackstadt R, et al: Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer. Clin Cancer Res 9: 710-720, 2012.
23. Zhang HS, Chen XY, Wu TC, Sang WW and Ruan Z: MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFkappaB pathway. FEBS Lett 586: 4203-4207, 2012.
24. Candas D, Fan M, Nantajit D, et al: CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol: Jan 31, 2013 (Epub ahead of print).
25. Haflidadottir BS, Bergsteinsdottir K, Praetorius C and Steingrimsson E: miR-148 regulates Mitf in melanoma cells. PloS One 5: e11574, 2010.
26. Iovino N, Pane A and Gaul U: miR-184 has multiple roles in Drosophila female germline development. Dev Cell 17: 123-133, 2009.
27. Liu C, Teng ZQ, Santistevan NJ, et al: Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 6: 433-444, 2010.
28. Chen Y, Tsai YH and Tseng SH: Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN- survivin pathway. Surgery 153: 4-16, 2013.
29. Zhang C, Yao Z, Zhu M, et al: Inhibitory effects of microRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting Notch1. J Huazhong Univ Sci Technolog Med Sci 32: 375-382, 2012.
30. Venta R, Valk E, Koivomagi M and Loog M: Double-negative feedback between S-phase cyclin-CDK and CKI generates abruptness in the G1/S switch. Front Physiol 3: 459, 2012.
31. Nagle AA, Gan FF, Jones G, So CL, Wells G and Chew EH: Induction of tumor cell death through targeting tubulin and evoking dysregulation of cell cycle regulatory proteins by multifunctional cinnamaldehydes. PloS One 7: e50125, 2012.
32. Chow JP and Poon RY: The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery. Oncogene: Nov 12, 2012 (Epub ahead of print).
33. Guarnieri V, Battista C, Muscarella LA, et al: CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cell Oncol (Dordr) 35: 411-422, 2012.
34. Amrich CG, Davis CP, Rogal WP, et al: Cdc73 subunit of Paf1 complex contains C-terminal Ras-like domain that promotes association of Paf1 complex with chromatin. J Biol Chem 287: 10863-10875, 2012.
35. Zhang JH, Seigneur EM, Pandey M, et al: The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome. Cell Death Dis 3: 266, 2012.
36. Masi G, Barzon L, Iacobone M, et al: Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15: 1115-1126, 2008.
37. Jiang Y, Zhang XY, Sun L, et al: Methyl methanesulfonate induces apoptosis in p53-deficient H1299 and Hep3B cells through a caspase 2- and mitochondria-associated pathway. Environ Toxicol Pharmacol 34: 694-704, 2012.
38. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A and Young BD: MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916, 2007. (Pubitemid 46672066)
39. Shin KH, Bae SD, Hong HS, Kim RH, Kang MK and Park NH: miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun 404: 896-902, 2011.
40. Xie W, Li Z, Li M, Xu N and Zhang Y: miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun 430: 647-652, 2012.
41. Kashat M, Azzouz L, Sarkar SH, Kong D, Li Y and Sarkar FH: Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am J Transl Res 4: 432-442, 2012.
42. Xia J, Duan Q, Ahmad A, et al: Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets 13: 1750-1756, 2012.